1. Werner, Haim, Sarfstein, Rive. 2014. Transcriptional and epigenetic control of IGF1R gene expression: implications in metabolism and cancer. In Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 24, 112-8. doi:10.1016/j.ghir.2014.03.006. https://pubmed.ncbi.nlm.nih.gov/24863809/
2. Zheng, Ke, Sha, Nannan, Hou, Guofang, Jiang, Yuhui, Chen, Tao. 2023. IGF1R-phosphorylated PYCR1 facilitates ELK4 transcriptional activity and sustains tumor growth under hypoxia. In Nature communications, 14, 6117. doi:10.1038/s41467-023-41658-z. https://pubmed.ncbi.nlm.nih.gov/37777542/
3. Wei, Yongzhen, Jiang, Huan, Li, Fengjuan, Wang, Yuan, Zhao, Qiang. 2024. Extravascular administration of IGF1R antagonists protects against aortic aneurysm in rodent and porcine models. In Science translational medicine, 16, eadh1763. doi:10.1126/scitranslmed.adh1763. https://pubmed.ncbi.nlm.nih.gov/38691618/
4. Chrudinová, Martina, Kirk, Nicholas S, Chuard, Aurelien, Jiráček, Jiří, Altindis, Emrah. 2024. A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression. In Molecular metabolism, 80, 101863. doi:10.1016/j.molmet.2023.101863. https://pubmed.ncbi.nlm.nih.gov/38182007/